Could Adjunctive Pharmacology Mitigate Cardiovascular Consequences of Obstructive Sleep Apnea?

Najib T Ayas^{1

2

3

4}, Glen E Foster^{4

5}, Neomi Shah⁶, John Floras⁷, Ismail Laher^{8

4}

Affiliations

¹ Sleep Disorders Program.
² Division of Respiratory Medicine and.
³ Division of Critical Care Medicine, Department of Medicine, and.
⁴ Canadian Sleep and Circadian Network and.
⁵ Centre for Heart, Lung, and Vascular Health, School of Health and Exercise Science, University of British Columbia, Kelowna, British Columbia, Canada.
⁶ Division of Pulmonary, Critical Care, and Sleep, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; and.
⁷ Division of Cardiology, Department of Medicine, University Health Network and Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
⁸ Department of Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Najib T Ayas et al. Am J Respir Crit Care Med. 2019.

. 2019 Sep 1;200(5):551-555.

doi: 10.1164/rccm.201811-2097PP.

Najib T Ayas^{1

2

3

4}, Glen E Foster^{4

5}, Neomi Shah⁶, John Floras⁷, Ismail Laher^{8

4}

¹ Sleep Disorders Program.
² Division of Respiratory Medicine and.
³ Division of Critical Care Medicine, Department of Medicine, and.
⁴ Canadian Sleep and Circadian Network and.
⁵ Centre for Heart, Lung, and Vascular Health, School of Health and Exercise Science, University of British Columbia, Kelowna, British Columbia, Canada.
⁶ Division of Pulmonary, Critical Care, and Sleep, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; and.
⁷ Division of Cardiology, Department of Medicine, University Health Network and Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
⁸ Department of Anesthesiology, Pharmacology, and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

No abstract available

Figures

Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease, and Heart Failure with Preserved Ejection Fraction: A Cardiopulmonary Perspective.
Mehmood M. Mehmood M. Am J Respir Crit Care Med. 2020 Feb 15;201(4):500. doi: 10.1164/rccm.201909-1780LE. Am J Respir Crit Care Med. 2020. PMID: 31647719 Free PMC article. No abstract available.

1. Floras JS. Sleep apnea and cardiovascular disease: an enigmatic risk factor. Circ Res. 2018;122:1741–1764. - PubMed
1. Jelic S, Lederer DJ, Adams T, Padeletti M, Colombo PC, Factor PH, et al. Vascular inflammation in obesity and sleep apnea. Circulation. 2010;121:1014–1021. - PMC - PubMed
1. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73:3168–3209. - PubMed
1. Roure N, Gómez S, Mediano O, Duran J, Peña M de L, Capote F, et al. Daytime sleepiness and polysomnography in obstructive sleep apnea patients. Sleep Med. 2008;9:727–731. - PubMed
1. McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, et al. SAVE Investigators and Coordinators. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016;375:919–931. - PubMed